New York, NY (PRWEB) May 19, 2014
Thousands of transvaginal mesh lawsuits (http://www.transvaginalmeshlawsuithelp.com/) filed against American Medical Systems, Inc. continue to move forward in a consolidated litigation underway in U.S. District Court, Southern District of West Virginia, Bernstein Liebhard LLP reports. On May 16, 2014, the Court approved a new Docket Control Order pertaining to the litigation’s third round of bellwether trials. Among other things, the Order stipulates that all discovery, including depositions of all company witnesses and third parties, will be completed by July 14, 2014. Dates for pretrial and settlement conferences, as well as the start date for the trial itself, will be determined by the Court at a future Status Conference. (In Re American Medical Systems, Inc. - MDL No. 2325)
“Our Firm is representing numerous women in this proceeding who allegedly suffered life-changing vaginal mesh complications due to products manufactured by American Medical Systems. We are pleased to see this proceeding moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to evaluate vaginal mesh lawsuits on behalf of women who suffered mesh erosion, chronic pain, and organ damage, allegedly due to devices marketed by American Medical Systems, as well as Boston Scientific Corp., C.R. Bard, Inc. and Ethicon, Inc.
Vaginal Mesh Lawsuits
According to court documents, tens of thousands of vaginal mesh lawsuits have been filed against American Medical Systems in courts around the country. The vast majority of claims are pending in the Southern District of West Virginia, where Bernstein Liebhard LLP partner, Jeffrey S. Grand, is serving on the Plaintiffs’ Steering Committee.
On April 30, 2014, Endo International PLC, the parent company of American Medical Systems, announced a settlement agreement that could potentially resolve some 20,000 transvaginal mesh lawsuits pending against the company. Among other things, Endo indicated that it has set aside $830 million to cover the settlement agreement, which is expected to be implemented over the next year. Endo did not admit liability or fault for any plaintiffs’ alleged vaginal mesh complications in agreeing to the settlement plan.*
According to court filings, American Medical Systems is just one of several companies named in vaginal mesh lawsuits in the Southern District of West Virginia. In addition to his work on that litigation, Mr. Grand is also serving on the Plaintiffs' Steering Committees in several proceedings established in that jurisdiction that involve Boston Scientific Corp., (MDL 2326), C.R. Bard, Inc. (MDL 2325) and Ethicon, Inc. (MDL No. 2327).
Mr. Grand is also serving as Co-Liaison Counsel in two consolidated proceedings established for C.R. Bard and Ethicon mesh lawsuits in New Jersey's Atlantic Superior Court. He was also a member of the plaintiff’s trial team for the first Ethicon trial, which ended in March with an $11 million verdict for the Plaintiff. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10; In re: Pelvic Mesh Litigation/Bard, No. L-6339-10).
Alleged victims of serious vaginal mesh complications may be entitled to compensation for their injury-related damages. To learn more about filing a transvaginal mesh lawsuit, please visit Bernstein Liebhard LLP's website or the Firm's Facebook page: https://www.facebook.com/meshlawsuit. To obtain a free, confidential and no-obligation case review, please call 800-511-5092.
*phx.corporate-ir.net/phoenix.zhtml?c=231492&p=irol-newsArticle_Print&ID=1924548&highlight=, Endo International PLC, April 30, 2014
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP represents the victims of defective drugs and medical devices on a contingency-fee basis, and our clients are never expected to pay attorneys fees unless their case results in a successful recovery on their behalf. New York State’s contingency fee cap rules generally limit those fees to 33 1/3% of the total recovery. As a result, the Firm’s fees can be significantly lower than those assessed by attorneys in other states, which depending on the law may amount to as much as 40% or more of a plaintiff’s recovery.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP